Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Starting Lexapro (escitalopram) commonly triggers a temporary increase in anxiety, jitteriness, restlessness, or broken sleep during the first one to two weeks, because serotonin levels shift and receptors need time to adapt before the calming benefit appears. This early "activation" phase usually peaks in the first several days and settles by weeks two to four, though a higher starting dose, caffeine, poor sleep, or an underlying panic or bipolar tendency can make it feel stronger and last longer. Signs that are not part of normal adjustment, such as severe agitation, new or worsening suicidal thoughts, racing thoughts with no need for sleep, or tremor with fever and confusion, call for prompt medical attention rather than waiting it out. There are several factors, timelines, and warning signs to consider, and the important details are explained below.
Because normal start-up jitters and a genuine warning sign can feel nearly identical, it is worth taking a few minutes for a free, instant, online symptom check to see how your specific pattern lines up, what questions to bring to your prescriber, and whether you should be seen sooner rather than later.
Last reviewed for medical accuracy: 09/13/2026
Why Do I Feel More Anxious During the First Two Weeks on Lexapro?
Starting Lexapro (escitalopram) can feel like a roller-coaster: you’re hoping for relief from anxiety or depression, yet during the first 10–14 days you might actually feel more anxious. Understanding why this happens—and which Lexapro side effects are expected—can help you stay on track and know when to reach out for help.
Lexapro is a selective serotonin reuptake inhibitor (SSRI). It raises serotonin levels in your brain by blocking its reabsorption (reuptake) into nerve cells. Serotonin is a neurotransmitter that helps regulate mood, sleep and appetite.
Many people starting Lexapro notice side effects that tend to peak early and ease with time. Here are the most frequently reported:
These reactions generally aren’t dangerous—they’re signs your body is adapting. Staying informed can reduce worry about normal adjustments.
Serotonin “Shock”
Receptor Sensitivity
Psychological Factors
In most cases, these effects wane within 1–2 weeks as receptors adjust and your nervous system settles into a new balance.
While you wait for Lexapro to take full effect, you can ease discomfort with practical steps:
These strategies often help you get through those first two weeks with fewer Lexapro side effects and less overall stress.
Most early side effects improve by week three or four. However, contact your prescriber if you experience any of the following:
Any of these could signal a serious reaction or need for dose adjustment.
If you’re unsure whether your experience is within the expected range of Lexapro side effects, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Remember that Lexapro’s full benefits often don’t show up until you’ve been on it for at least 4–6 weeks. Most people find that once the body adapts:
Patience and communication with your healthcare provider are key.
Disclaimer
This information is not a substitute for professional medical advice. If you have serious or life-threatening symptoms—especially thoughts of self-harm—speak to a doctor or go to the nearest emergency department right away. Always review any concerns or persistent side effects with your prescribing physician.
(References)
* Rao N. The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet. 2007;46(4):281-90. doi: 10.2165/00003088-200746040-00002. PMID: 17375980.
* Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019 Feb 23;393(10173):768-777. doi: 10.1016/S0140-6736(18)31793-8. Epub 2019 Jan 31. PMID: 30712879.
* Prabhakar D, Sablaban I. Escitalopram-Induced Rash. Prim Care Companion CNS Disord. 2019 Jan 31;21(1):18l02302. doi: 10.4088/PCC.18l02302. Epub 2019 Jan 31. PMID: 30806996.
* Tirmazi SI, Imran H, Rasheed A, Mushtaq S. Escitalopram-Induced Hair Loss. Prim Care Companion CNS Disord. 2020 Jun 25;22(4):19l02496. doi: 10.4088/PCC.19l02496. Epub 2020 Jun 25. PMID: 32589827.
* Strawn JR, Mills JA, Schroeder H, Mossman SA, Varney ST, Ramsey LB, Poweleit EA, Desta Z, Cecil K, DelBello MP. Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study. J Clin Psychiatry. 2020 Aug 25;81(5):20m13396. doi: 10.4088/JCP.20m13396. Epub 2020 Aug 25. PMID: 32857933; PMCID: PMC7504974.
* Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Jan 1;80(1):13-21. doi: 10.1001/jamapsychiatry.2022.3679. PMID: 36350591; PMCID: PMC9647561.
* Verhoeven JE, Han LKM, Lever-van Milligen BA, Hu MX, Révész D, Hoogendoorn AW, Batelaan NM, van Schaik DJF, van Balkom AJLM, van Oppen P, Penninx BWJH. Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders. J Affect Disord. 2023 May 15;329:19-29. doi: 10.1016/j.jad.2023.02.064. Epub 2023 Feb 23. PMID: 36828150.
* Fagan HA, Baldwin DS. Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions. Expert Rev Neurother. 2023 Jun;23(6):535-548. doi: 10.1080/14737175.2023.2211767. Epub 2023 May 15. PMID: 37183813.
* Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Epub 2023 Nov 28. PMID: 38014714; PMCID: PMC10683020.
* Yan N, Hu S. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial. BMC Psychiatry. 2024 May 15;24(1):365. doi: 10.1186/s12888-024-05833-w. Epub 2024 May 15. PMID: 38750479; PMCID: PMC11094958.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.